MHK three-lens brief
Evidence-based stock research on MHK. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Underperforming SPY by 13.0pp over 30 days. · Trading at 10% of its 52-week range — deep in the lower band.
- Trading at 10% of its 52-week range — deep in the lower band.
- Underperforming SPY by 13.0pp over 30 days.
- Analyst mean target $120.47 — 22% above current (15 analysts).
- Debt-to-equity of 30.1 — balance-sheet-heavy.
MHK closed at $98.73 (-0.75%) as of 2026-05-13. Market cap: $6.02B. P/E (trailing) 14.8. Positives: analyst mean target $120.47 — 22% above current (15 analysts).. Concerns: trading at 10% of its 52-week range — deep in the lower band.; underperforming SPY by 13.0pp over 30 days.. Last quarter: Revenue $2.73B, net income $117.10M.
Why three lenses on MHK, not one.
A single reasoning model has blind spots it doesn’t know about. We examine MHKacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/MHK" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath MHK brief"></iframe>